Twin Peaks Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
1,236
+34
+3% +$34.5K 0.29% 66
2025
Q4
$1.26M Buy
1,202
+150
+14% +$143K 0.37% 60
2025
Q3
$803K Sell
1,052
-26
-2% -$19.3K 0.27% 69
2025
Q2
$689K Buy
1,078
+250
+30% +$194K 0.22% 75
2025
Q1
$627K Buy
828
+46
+6% +$38.3K 0.29% 73
2024
Q4
$604K Buy
782
+47
+6% +$38.9K 0.26% 70
2024
Q3
$651K Buy
735
+23
+3% +$20.7K 0.3% 68
2024
Q2
$645K Sell
712
-6
-0.8% -$4.8K 0.32% 61
2024
Q1
$559K Buy
718
+14
+2% +$9.96K 0.31% 63
2023
Q4
$410K Buy
+704
New +$411K 0.26% 73

Other funds holding LLY

Twin Peaks Wealth Advisors's LLY Position: Q1 2026 in Review

Twin Peaks Wealth Advisors increased its Eli Lilly (LLY) stake by 2.8% in Q1 2026, buying an estimated $34.5K and bringing the position to 1,236 shares worth $1.14M. The position accounts for 0.29% of the portfolio, ranked #66.

Twin Peaks Wealth Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.26M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Twin Peaks Wealth Advisors held 1,236 shares of Eli Lilly worth $1.14M as of Q1 2026.
  • Twin Peaks Wealth Advisors bought 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
  • Eli Lilly made up 0.29% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #66 holding.
  • Twin Peaks Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Twin Peaks Wealth Advisors's Eli Lilly position peaked at $1.26M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.